CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Study of L19IL2/L19TNF in Patients With Skin Cancers Amenable to Intralesional Treatment
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05329792
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:32.321113+00:00
- Published At
- 2023-10-06T00:00:00+00:00
- Record Updated At
- 2023-10-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["BCC - Basal Cell Carcinoma", "SCC - Squamous Cell Carcinoma", "Merkel Cell Carcinoma", "Keratoacanthoma of Skin", "Malignant Adnexal Tumors of the Skin (MATS)", "Tumors From Cutaneous T-cell Lymphoma (CTCL)", "Kaposi Sarcoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-06"- protocolSection.identificationModule.nctId
"NCT05329792"- protocolSection.identificationModule.officialTitle
"A Phase II Study of L19IL2/L19TNF in Patients With Skin Cancers Amenable to Intralesional Treatment"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.